Bilateral Chylothorax Following Modified Radical Neck Dissection in Thyroid Cancer: A Case Report / 대한내분비외과학회지

Bilateral chylothoraxis an extremely rare complication of modified radical neck dissection. It is a potentially life-threatening condition that can lead to severe respiratory, nutritional, metabolic, and immunologic disorders. Use of a multi-disciplinary approach including drainage of chyle, reduction of chyle formation, adequate nutritional support, use of somatostatin or its analogue, surgical ligation of the thoracic duct, and thoracic duct embolization is the best method for treatment of bilateral chylothorax. We report on a case of bilateral chylothorax following total thyroidectomy with modified radical neck dissection and discuss its management.

Outcomes of Critical Pathway in Laparoscopic and Open Surgical Treatments for Gastric Cancer Patients: Patients Selection for Fast-Track Program through Retrospective Analysis

PURPOSE: The aim of this study is to investigate the clinical factors affecting on the cure rate by invasive and open surgery for gastric cancer and to establish a subgroup of patients who can be applied by the early recovery after surgery program through this retrospective analysis. MATERIALS AND METHODS: In this retrospective study, we analyzed 425 patients who underwent gastric cancer surgery between January 2011 and December 2011 and were managed with conventional clinical therapies. This clinical algorithm was made when the patient was in minimally invasive surgery group and discharged from hospital one day faster than them in open surgery group. RESULTS: The completion rate of the clinical pathway was 62.4%. Despite the different applications of clinical pathway, completion rate in minimally invasive surgery group was significantly higher than that of open group (P<0.001). In multivariate analysis, the surgical procedure of minimally invasive surgery (odds ratio=4.281) was the most predictable factor to complete clinical pathway. Additionally, younger patients (odds ratio=1.933) who underwent distal gastrectomy (odds ratio=1.999) without combined resection (odds ratio=3.069) were predicted to accomplish the clinical pathway without any modifications. CONCLUSIONS: We concluded that high efficacy of the clinical pathway for gastric cancer surgery was expected to selected patients through retrospective analysis (expected completion rate=85.4%). In addition, these patients would become enrolled criteria for early recovery program in gastric cancer surgery.